Insider Transactions in Q2 2025 at Biogen Inc. (BIIB)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2025
|
Monish D Patolawala Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+38.98%
|
-
|
|
Jun 17
2025
|
Lloyd Minor Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+50.0%
|
-
|
|
Jun 17
2025
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+25.8%
|
-
|
|
Jun 17
2025
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+21.1%
|
-
|
|
Jun 17
2025
|
Jesus B Mantas Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+19.54%
|
-
|
|
Jun 17
2025
|
Stephen A Sherwin Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+14.76%
|
-
|
|
Jun 17
2025
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+8.87%
|
-
|
|
Jun 17
2025
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,160
+9.25%
|
-
|
|
Jun 17
2025
|
Susan Langer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,370
+31.6%
|
-
|
|
May 19
2025
|
Priya Singhal Head of Development |
SELL
Open market or private sale
|
Direct |
3,806
-41.22%
|
$479,556
$126.25 P/Share
|
|
May 02
2025
|
Caroline Dorsa Director |
BUY
Open market or private purchase
|
Direct |
1,235
+4.25%
|
$150,670
$122.72 P/Share
|
|
May 01
2025
|
Adam Keeney Head of Corporate Development |
SELL
Payment of exercise price or tax liability
|
Direct |
454
-16.0%
|
$54,480
$120.93 P/Share
|
|
May 01
2025
|
Adam Keeney Head of Corporate Development |
BUY
Exercise of conversion of derivative security
|
Direct |
938
+24.84%
|
-
|